Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The Life Enhancement Treatment for Substance Use (LETS Act!)

Journal of Clinical Psychiatry

Volumn 69, Issue 1, 2008, Pages 122-129

  Daughters, Stacey B ^a   Braun, Ashley R ^a   Sargeant, Marsha N ^a   Reynolds, Elizabeth K ^a   Hopko, Derek R ^c   Blanco, Carlos ^b   Lejuez, C W ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; PSYCHOTROPIC AGENT;

ADULT; ANXIETY; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG DETOXIFICATION; FEMALE; FOLLOW UP; HAMILTON SCALE; HOSPITAL PATIENT; HUMAN; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; REWARD; SUBSTANCE ABUSE;

EID: 39549113175     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0116     Document Type: Article

References (47)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990;264:2511-2518
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105
3. Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry 2006;67:1062-1073
4. Hasin DS, Nunes EV. Comorbidity of alcohol, drug, and psychiatric disorders: epidemiology. In: Kranzler HR, Rounsaville BJ, eds. Dual Diagnosis and Treatment: Substance Abuse and Psychiatric Disorders. New York, NY: Marcel Decker, Inc; 1997:1-31
5. Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry 2004;56:793-802
6. Rounsaville BJ, Anton SF, Carroll K, et al. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991;48:43-51
7. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995;56(suppl 3):19-24
8. Brown RA, Monti PM, Myers MG et al. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry 1998;155:220-225
9. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 1996;37:43-49
10. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 1986;43:733-738
11. McKay JR, Pettinati HM, Morrison R, et al. Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav 2002;16:225-235
12. Rounsaville BJ. Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Arch Gen Psychiatry 1982;39:151-156
13. Rounsaville BJ, Kosten TR, Weissman MM, et al. Prognostic significance of psychopathology in treated opiate addicts: a 2.5-year follow-up study. Arch Gen Psychiatry 1986;43:739-745
14. Tate SR, Brown SA, Unrod M, et al. Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders. Addict Behav 2004;29:1707-1724
15. Thase ME, Salloum IM, Cornelius JD. Comorbid alcoholism and depression: treatment issues. J Clin Psychiatry 2001;62:32-41
16. Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiatry 2004;56:714-717
17. Watkins KE, Paddock SM, Zhang L, et al. Improving care for depression patients with comorbid substance misuse. Am J Psychiatry 2006;163:125-132
18. Carpenter KM, Brooks AC, Vosburg SK, et al. The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial. Drug Alcohol Depend 2004;74:123-134
19. McDowell D, Nunes EV, Seracini AM. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend 2005;80:209-221
20. Carroll KM. Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry 2004;56:778-784
21. Rounsaville BJ. Treatment of cocaine dependence and depression. Biol Psychiatry 2004;56:803-809
22. Brown RA, Evans DM, Miller IW, et al. Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol 1997;65:715-726
23. Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 1994;62:141-146
24. Hall SM, Muñoz RF, Reus VI, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol 1996;64:1003-1009
25. Morgenstern J, Blanchard KA, Morgan TJ, et al. Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and post treatment findings. J Consult Clin Psychol 2001;69:1007-1017
26. Aharonovich E, Hasin DS, Brooks AC, et al. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006;81:313-322
27. McCoy HV, Messiah SE, Zhao W. Improving access to primary health care for chronic drug users: an innovative systemic intervention for providers. J Behav Health Serv Res 2002;29:445-457
28. Hopko DR, Lejuez CW, Ruggiero KJ, et al. Contemporary behavioral activation treatments for depression: procedures, principles, and progress. Clin Psychol Rev 2003;23:699-717
29. Jacobson NS, Dobson KS, Truax PA, et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol 1996;64:295-304
30. Lewinsohn PM. A behavioral approach to depression. In: Friedman RM, Katz MM, eds. The Psychology of Depression: Contemporary Theory and Research. New York, NY: Wiley; 1974
31. Lewinsohn PM, Graf M. Pleasant activities and depression. J Consult Clin Psychol 1973;41:261-268
32. Zeiss AM, Lewinsohn PM, Muñoz RF. Nonspecific improvement effects in depression using interpersonal skills training, pleasant activity schedules, or cognitive training. J Consult Clin Psychol 1979;47:427-439
33. Lejuez CW, Hopko DR, Hopko SD. A brief behavioral activation treatment for depression: treatment manual. Behav Modif 2001;25:255-286
34. Hopko DR, Bell JL, Armento ME, et al. Behavior therapy for depressed cancer patients in primary care. Psychotherapy Theory Res Pract 2005;42:236-243
35. Hopko DR, Lejuez, CW, LePage JP, et al. A randomized pilot trial of a brief behavioral activation treatment for depression (BATD) within an inpatient psychiatric hospital. Behav Modif 2003;27:458-469
36. Lejuez CW, Hopko DR, LePage JP, et al. A brief behavioral activation treatment for depression. Cogn Behav Pract 2001;8:164-175
37. Beck AT, Steer RA, Ball R, et al. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996;67:588-597
38. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
39. Kirisci L, Vanyukov M, Dunn M, et al. Item response theory modeling of substance use: an index based on 10 drug categories. Psychol Addict Behav 2002;16:290-298
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
41. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897
42. Armento ME, Hopko DR. The Environmental Reward Observation Scale (EROS): development, validity, and reliability. Behav Ther 2007;38:107-119
43. Larsen DL, Attkission CC, Hargreaves WA, et al. Assessment of client/ patient satisfaction: development of a general scale. Eval Program Plann 1979;2:197-207
44. Daley DC, Salloum IM, Zuckoff A, et al. Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study. Am J Psychiatry1998;155:1611-1613
45. Weiss RD, Kolodziej ME, Najavits LM, et al. Utilization of psychosocial treatments by patients diagnosed with bipolar disorder and substance dependence. Am J Addict 2000;9:314-320
46. Milby JB, Schumacher JE, Wallace D, et al. Day treatment with contingency management for cocaine abuse in homeless persons: 12-month follow-up. J Consult Clin Psychol 2003;71:619-662
47. Hopko DR, Bell JL, Armento MEA, et al. CBATD for depressed cancer patients in a medical care setting. Behav Ther. In press